This study demonstrated that the treatment with CA resulted in the decline of serum levels of NF-κB, NrF2, and IL-6 in PCOS rats which resulted in a reduced risk of chronic inflammation. This evidence concerns the gene NFKB1 and polycystic ovary syndrome.